Scott Habig

Equibles does not estimate personal net worth.

About Scott Habig

Aurinia Pharmaceuticals Inc. reported in an 8-K filed November 7, 2024 that Scott Habig was terminated as Chief Commercial Officer. The proxy statement of Aurinia Pharmaceuticals Inc. reports total compensation of $2,785,746 for Scott Habig in fiscal 2022, including a base salary of $206,250.

“Aurinia plans to terminate its employment relationship with Scott Habig.”

Aurinia Pharmaceuticals Inc. Form 8-K, filed November 7, 2024 · Read the filing

Affiliation history

Aurinia Pharmaceuticals Inc. (AUPH)
Proxy statement

Start not stated–2024-11-07

Company network

Aurinia Pharmaceuticals Inc.

AUPH

Biotechnology · Healthcare

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Aurinia Pharmaceuticals Inc. (AUPH)	Former Chief Commercial Officer	$206,250	$100,000	$1,125,004	$1,124,999	$225,000	$4,493	$2,785,746

Recent activity

Executive change Terminated: Chief Commercial Officer Aurinia Pharmaceuticals Inc. (AUPH)
2024-11-07